US Stock MarketDetailed Quotes

ENTA Enanta Pharmaceuticals

Watchlist
  • 11.245
  • -0.245-2.13%
Close Oct 31 16:00 ET
  • 11.245
  • 0.0000.00%
Post 16:00 ET
238.27MMarket Cap-2063P/E (TTM)

Enanta Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Enanta Pharmaceuticals Q4 2024 Estimates Date

Currency：USDNov 25, 2024

Estimate YoY
Revenue
17.83M
-5.83%
EPS
-1.07
+19.33%
Analyst Rating
Buy

Oct 31, 2024

Enanta Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 18.599M--
Nov 25, 20242024/Q4-- / 17.828M--
Aug 5, 20242024/Q317.971M / 17.156M--
May 6, 20242024/Q217.054M / 16.207M--
Feb 7, 20242024/Q118.003M / 21.946M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 18.599M--
Nov 25, 20242024/Q4-- / 17.828M--
Aug 5, 20242024/Q317.971M / 17.156M--
May 6, 20242024/Q217.054M / 16.207M--
Feb 7, 20242024/Q118.003M / 21.946M--

Unlock Free Earnings Estimates

Enanta Pharmaceuticals Earnings Reports

  • Enanta Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Aug 7 16:02 ET

  • Enanta Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    May 8 16:04 ET

  • Enanta Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

    Feb 8 16:26 ET

  • Enanta Pharmaceuticals | 10-K: FY2023 Annual Report

    Nov 22, 2023 16:21 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 31, 2024

    Buy

    • Buy

      57.14%

    • Hold

      28.57%

    • Sell

      14.29%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data